Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)

Cancer Medicine
Bhavna PadhyeCraig F Munns

Abstract

Osteonecrosis (ON), a significant complication following treatment of acute lymphoblastic leukemia (ALL), has a profound impact on quality of life of ALL survivors. We studied incidence and outcome of ON in patients treated on or according to Australian and New Zealand Children's Haematology/ Oncology Group (ANZCHOG) study 8 at The Children's Hospital at Westmead. The study involved retrospective chart review of the patients. ON was defined by development of symptoms and confirmed by magnetic resonance imaging. From 2002-2011, 251 patients (143M, 108F, 59 Standard Risk (SR), 159 Medium Risk (MR) 5 High Risk (HR), and 28 Very high risk (VHR)) were treated according to study 8. Eighteen (7M, 11F, 2 SR, 12 MR, 4 VHR) patients developed ON (7.2%). Median age at diagnosis was 13.05 years(4.3-16.7). Incidence of ON in patients > 10 years at diagnosis was 29%. Six out of 18 patients developed ON after allogeneic stem cell transplantation. Median time from diagnosis to the development of ON following chemotherapy for ALL was 1.15 years (range 0.25-2.12). Most patients were treated with intravenous Zoledronic acid. At last follow-up, three patients had undergone arthroplasty, two patients were symptom free, and the remaining 13 patients...Continue Reading

References

May 24, 2000·Journal of Pediatric Orthopedics·S Y WeiJ P Dormans
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L A MattanoJ B Nachman
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J StraussL B Silverman
May 28, 2003·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Takeshi AsanoToshikazu Kubo
Nov 11, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·David G LittlePaul A Baldock
Jul 24, 2004·The Orthopedic Clinics of North America·Marvin E Steinberg, David R Steinberg
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary V RellingSue C Kaste
Jun 15, 2005·British Journal of Haematology·C D MitchellUNKNOWN Medical Research Council Childhood Leukaemia Working Party
Jul 19, 2005·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·David G LittleTony McEvoy
Mar 28, 2006·Journal of Pediatric Endocrinology & Metabolism : JPEM·ThiThuyAn Nguyen, Margaret R Zacharin
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Riitta A NiinimäkiMarjatta Lanning
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lei YangMary V Relling
Jun 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nina S Kadan-LottickCharles A Sklar
Apr 23, 2010·British Journal of Haematology·Jennifer L McNeer, James B Nachman
Jun 26, 2010·Archives of Disease in Childhood·M ElmantaserS F Ahmed
Sep 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mariël L te WinkelMarry M van den Heuvel-Eibrink
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen P HungerWilliam L Carroll
Aug 21, 2013·Seminars in Hematology·Ching-Hon Pui, William E Evans
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sue C KasteScott C Howard

❮ Previous
Next ❯

Citations

Jan 1, 2019·Expert Review of Endocrinology & Metabolism·Patrizia BruzziLorenzo Iughetti
Jan 31, 2019·Acta Oncologica·Riitta NiinimäkiTuukka Niinimäki
Jul 23, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Rosanna WustrackCarol D Morris
Aug 30, 2020·Pediatric Blood & Cancer·Lynne C JonesAdam S Levin
Sep 23, 2020·Current Osteoporosis Reports·Mercedes Rodriguez CelinGerald F Harris
Aug 10, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Rosanna WustrackCarol D Morris
Apr 24, 2020·Journal of Pediatric Hematology/oncology·Shanaz M DaneshdoostAdam S Levin
Jul 3, 2021·International Journal of Molecular Sciences·Vincent KuekLaurence C Cheung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.